HepatitisA

AVAXIM is indicated for active immunisation against infection caused by hepatitis A virus in susceptible adults and adolescents of 16 years of age and above.

AVAXIM is indicated for active immunisation against infection caused by hepatitis A virus in susceptible adults and adolescents of 16 years of age and above.

Active immunisation against infections caused by hepatitis A virus. The vaccine is particularly indicated for those at increased risk of infection or transmission.

Havrix Monodose Hepatitis A Vaccine 1ml pre-filled syringe with a separate needle suitable for IM injection.Inactivated hepatitis A virus vaccine in a suspension for injection.